Abstract

Neurodevelopmental disorders (NDDs) are a collection of diseases with early life onset that often present with developmental delay, cognitive deficits, and behavioral conditions. In some cases, severe outcomes such as brain malformations and intractable epilepsy can occur. The mutations underlying NDDs may be inherited or de novo, can be gain- or loss-of-function, and can affect one or more genes. Recent evidence indicates that brain somatic mutations contribute to several NDDs, in particular malformations of cortical development. While advances in sequencing technologies have enabled the detection of these somatic mutations, the mechanisms by which they alter brain development and function are not well understood due to limited model systems that recapitulate these events. Human brain organoids have emerged as powerful models to study the early developmental events of the human brain. Brain organoids capture the developmental progression of the human brain and contain human-enriched progenitor cell types. Advances in human stem cell and genome engineering provide an opportunity to model NDD-associated somatic mutations in brain organoids. These organoids can be tracked throughout development to understand the impact of somatic mutations on early human brain development and function. In this review, we discuss recent evidence that somatic mutations occur in the developing human brain, that they can lead to NDDs, and discuss how they could be modeled using human brain organoids.

Highlights

  • Neurodevelopmental disorders (NDDs) impact brain development and function resulting in a range of neurological and psychiatric manifestations

  • We describe emerging evidence that brain somatic mutations contribute to NDDs and discuss how human brain organoids’’ (hBOs) provide an opportunity to model and understand the consequences of somatic mutations during the early stages of human brain development

  • In addition to ‘‘mTORopathies’’, which are associated with cortical malformations and epilepsy (Karalis and Bateup, 2021), brain somatic mutations have been identified in tissue from individuals with a variety of disorders including Rett syndrome, neurofibromatosis type 1, neuronal migration disorders, epileptic encephalopathies, autism spectrum disorder (ASD), intellectual disability, schizophrenia, and neurodegenerative diseases (Muotri et al, 2010; Garcia-Linares et al, 2011; D’gama and Walsh, 2018; Park et al, 2019; Kim et al, 2021; Rodin et al, 2021)

Read more

Summary

Introduction

Neurodevelopmental disorders (NDDs) impact brain development and function resulting in a range of neurological and psychiatric manifestations. Advances in human stem cell and genome engineering provide an opportunity to model NDD-associated somatic mutations in brain organoids.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call